[Evaluation of continuous subcutaneous injection of peplomycin based on its pharmakinetics].
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D006258:Head and Neck Neoplasms / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008441:Maxillary Neoplasms / Q000378:metabolism; D017663:Peplomycin; D014062:Tongue Neoplasms / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D017663:Peplomycin